Friday, July 31, 2026

SK Hynix Secures 100 Trillion KRW Cash for AI Memory Dominance in 2026

SK Hynix CEO Kwak No-jung plans to secure over 100 trillion KRW for AI memory investments and aims for ADR listing in the U.S. market.

How the Late Lee Kun-hee’s 700 Billion Won Donation is Transforming Infectious Disease Research in Korea

The KDCA will host two international symposia on infectious disease research to enhance collaboration and response capabilities starting March 26.

LS Eco Energy Taps Into $150M Wind Project to Power 85,000 Homes

LS Eco Energy's LS-VINA will supply cables for a $150M wind project in the Philippines, boosting renewable energy efforts.

Tag: obesity

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Novo Nordisk Slashes GLP-1 Drug Prices by Up to 50%: What This Means for Obesity Treatments in 2027

Novo Nordisk will cut prices of GLP-1 treatments in the U.S. by up to 50% from January 2027, amid rising competition and market pressures.

Hanmi Posts Record $1.16B Sales and $193M Operating Profit: What’s Driving the 2025 Surge

Hanmi Pharmaceutical reports record sales of $1.16 billion in January 2025, with significant growth in profits and new product launches.

How a 2-Cent Sugar Tax Could Save $4.5 Billion in Healthcare Costs: California’s Bold Move

A sugar-sweetened beverage tax in California could cut obesity cases and save $4.5 billion in healthcare costs over ten years.

Chinese Biotech’s Rise: What’s the Standard of Global Tech Trade?

Analysts at the JPMHC noted a shift in biotech, with firms resisting sales and China emerging as a tech transfer leader.

Eli Lilly vs. Novo Nordisk: A $1.2 Billion Bet Reveals Two Very Different Futures for Obesity Drugs

Eli Lilly and Novo Nordisk are pursuing different strategies in the obesity treatment market, focusing on expansion versus core strengths.

Novo Nordisk’s Wegovy Pill Draws 3,000 Prescriptions in Its First Week—Is Oral GLP-1 Here to Stay?

Novo Nordisk's Wegovy oral obesity treatment saw over 3,000 prescriptions in its first week, indicating strong market demand.

Dark Skin Patches in Teens? It Could Be a Warning Sign, Doctors Say

Dark patches on skin folds in adolescents may indicate Acanthosis Nigricans, linked to obesity and insulin resistance. Consult a specialist.

Ozempic Maker Swaps CEO, Bets $2.2B on New Obesity Drug Fight

Novo Nordisk's leadership change aims to reclaim its obesity treatment market share amid competition from Eli Lilly's Mounjaro.

Novo Nordisk and Lilly Block Generics, Tighten Grip on $125B GLP-1 Market

Novo Nordisk and Eli Lilly secure court victories against generics, maintaining dominance in the GLP-1 treatment market amid rising demand.

Underweight People Face Higher Suicide Risk, Study Shows

A study reveals underweight individuals face a higher suicide risk, while overweight individuals show a lower risk, emphasizing BMI's impact.

Study Reveals Semaglutide Reduces Cravings and Helps Control Weight and Blood Sugar

A study shows oral semaglutide aids weight loss and reduces cravings for sugary foods in type 2 diabetes patients.

Could You Have Diabetes? Here’s What You Should Know About the Rising Numbers

In 2022, 14.8% of adults over 30 had diabetes; effective management remains a challenge despite rising awareness and lifestyle changes.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.